Ocean Biomedical announces loan commitment of up to $10 million from largest stockholder October 4, 2023
Ocean Biomedical’s cancer-targeting antibody candidate shows effective tumor reduction against a subset of NSCLC with EGFR mutations October 3, 2023
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor September 29, 2023
Ocean Biomedical provides update on programs in malaria, fibrosis, and multiple cancers August 10, 2023
Charles River Laboratories International, Inc Q2 2023 Earnings Conference Call Insights August 9, 2023
